Omapatrilat, an Angiotensin-Converting Enzyme and Neutral Endopeptidase Inhibitor, Attenuates Early Atherosclerosis in Diabetic and in Nondiabetic Low-Density Lipoprotein Receptor-Deficient Mice

By Levy Z.  

International Journal of Experimental Diabetes Research, Vol. 4, Iss. 1, 2003-01 ,pp. : 59-64

Informa Healthcare

Access to resources Recommend Favorite

Treatment of kidney transplants with chronic rejection using angiotensin-converting enzyme inhibitors

By Paredes D.   Sola R.   Guirado L.   Ibeas J.   Agraz I.   Vizcarra D.   Algaba F.  

Transplantation Proceedings, Vol. 29, Iss. 6, 1997-09 ,pp. : 2587-2588

Elsevier

Access to resources Recommend Favorite

The comparison of angiotensin-converting enzyme inhibitors with calcium antagonists in renal transplant patients under cyclosporin treatment

By Colak T.   Emiroglu R.   Karakayali H.   Bilgin N.   Haberal M.  

Transplantation Proceedings, Vol. 33, Iss. 5, 2001-08 ,pp. : 2774-2775

Elsevier

Access to resources Recommend Favorite

Angiotensin-Converting enzyme gene polymorphism significantly affects renal posttransplantation erythrocytosis

By Micozkadioglu H.   Colak T.   Akcay A.   Sezer S.   Atac F.B.   Verdi H.   Arat Z.   Ozemir F.N.   Haberal M.  

Transplantation Proceedings, Vol. 36, Iss. 1, 2004-01 ,pp. : 161-163

Elsevier

Access to resources Recommend Favorite

Factors associated with hospitalization of patients with angiotensin-converting enzyme inhibitor-induced angioedema

By Gang Cheng   Lindsell Christopher J.   Moellman Joseph   Sublett Wesley   Hart Kim   Collins Sean   Bernstein Jonathan A.  

Allergy and Asthma Proceedings, Vol. 34, Iss. 3, 2013-05 ,pp. : 267-273

OceanSide Publications, Inc

Access to resources Recommend Favorite